A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy

I8B-FW-ITRG -

The study will investigate how the body processes LY900014 and the effect of LY900014 on blood sugar levels in participants with Type 1 Diabetes on insulin injection therapy. Side effects and tolerability will be documented.

Trial Summary

Age Range
18 - 65 years
Conditions the trial is for
Type 1 Diabetes
What the trial is testing?
Insulin Lispro, LY900014
Could I receive a Placebo?
No
Enrollment Goal
30
Trial Dates
Mar 1, 2016 - Jul 1, 2016
How long will I be in the trial?
Your participation could last up to 14 weeks and include 13 visits to the study center.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.